{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:47:36Z","timestamp":1761155256509},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,11,30]],"date-time":"2008-11-30T00:00:00Z","timestamp":1228003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s12032-008-9136-1","type":"journal-article","created":{"date-parts":[[2008,11,29]],"date-time":"2008-11-29T13:29:04Z","timestamp":1227965344000},"page":"402-408","source":"Crossref","is-referenced-by-count":4,"title":["The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in\u00a0vivo study"],"prefix":"10.1007","volume":"26","author":[{"given":"Fazilet \u00d6ner","family":"Din\u00e7ba\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didem \u00c7olpan","family":"\u00d6ks\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Atalar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuncay","family":"Altug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eennur","family":"\u0130lvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nursal","family":"Gedik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevda","family":"\u00d6zel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"Koca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,30]]},"reference":[{"key":"9136_CR1","first-page":"357","volume-title":"Principles and practice of radiation oncology","author":"LS Constine","year":"2004","unstructured":"Constine LS, Williams JP, Morris M, Rubin P, Okunieff P. Late effects of cancer treatment on normal tissues. In: Perez CA, Brady LW, Halperin EC, Schm\u0131dt-Ullrich RK, editors. Principles and practice of radiation oncology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 357\u201390.","edition":"4"},{"issue":"A","key":"9136_CR2","first-page":"401","volume":"20","author":"S Mose","year":"2000","unstructured":"Mose S, et al. Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines. Anticancer Res. 2000;20(A):401\u20135.","journal-title":"Anticancer Res"},{"key":"9136_CR3","first-page":"3218","volume":"54","author":"DS Shewach","year":"1994","unstructured":"Shewach DS, Hahn TM, Chang E, Hertel LW, Lawrence TS. Metabolism of 2\u20322\u2032-difluoro-2\u2032-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res. 1994;54:3218\u201323.","journal-title":"Cancer Res"},{"key":"9136_CR4","first-page":"107","volume":"59","author":"L Milas","year":"1999","unstructured":"Milas L, et al. Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res. 1999;59:107\u201314.","journal-title":"Cancer Res"},{"key":"9136_CR5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0360-3016(99)00134-0","volume":"44","author":"KA Mason","year":"1999","unstructured":"Mason KA, et al. Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys. 1999;44:1125\u201335. doi: 10.1016\/S0360-3016(99)00134-0 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9136_CR6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0360-3016(00)00447-8","volume":"47","author":"MT Fields","year":"2000","unstructured":"Fields MT, et al. Radiosensitization produced in vivo by once vs twice weekly 2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine (gemcitabine). Int J Radiat Oncol Biol Phys. 2000;47:785\u201391. doi: 10.1016\/S0360-3016(00)00447-8 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9136_CR7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1200\/JCO.2001.19.3.792","volume":"19","author":"A Eisbruch","year":"2001","unstructured":"Eisbruch A, et al. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. J Clin Oncol. 2001;19:792\u20139.","journal-title":"J Clin Oncol"},{"issue":"7","key":"9136_CR8","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1200\/JCO.1999.17.7.2208","volume":"17","author":"AW Blackstock","year":"1999","unstructured":"Blackstock AW, et al. Phase I trial of twice weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J Clin Oncol. 1999;17(7):2208\u201312.","journal-title":"J Clin Oncol"},{"key":"9136_CR9","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1200\/JCO.2000.18.19.3384","volume":"18","author":"MS Talamonti","year":"2000","unstructured":"Talamonti MS, et al. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol. 2000;18:3384\u20139.","journal-title":"J Clin Oncol"},{"key":"9136_CR10","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/sj.bjc.6600256","volume":"86","author":"M Ikeda","year":"2002","unstructured":"Ikeda M, Okada S, Tokuuye K, Ueno H, Okusaka T. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer. Br J Cancer. 2002;86:1551\u20134. doi: 10.1038\/sj.bjc.6600256 .","journal-title":"Br J Cancer"},{"key":"9136_CR11","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2001.19.22.4202","volume":"19","author":"CJ McGinn","year":"2001","unstructured":"McGinn CJ, et al. Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 2001;19:4202\u20138.","journal-title":"J Clin Oncol"},{"key":"9136_CR12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0360-3016(01)01580-2","volume":"50","author":"JM Pipas","year":"2001","unstructured":"Pipas JM, et al. Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2001;50:1317\u201322. doi: 10.1016\/S0360-3016(01)01580-2 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9136_CR13","first-page":"804","volume":"20","author":"L Trodella","year":"2002","unstructured":"Trodella L, et al. Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer. J Clin Oncol. 2002;20:804\u201310. doi: 10.1200\/JCO.20.3.804 .","journal-title":"J Clin Oncol"},{"issue":"13","key":"9136_CR14","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1200\/JCO.2004.10.070","volume":"22","author":"E Kent","year":"2004","unstructured":"Kent E, et al. Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a Phase I trial. J Clin Oncol. 2004;22(13):2540\u20135. doi: 10.1200\/JCO.2004.10.070 .","journal-title":"J Clin Oncol"},{"issue":"2","key":"9136_CR15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijrobp.2004.05.074","volume":"61","author":"VK Sangar","year":"2005","unstructured":"Sangar VK, et al. Phase I study of conformal radiotherapy with concurrent Gemcitabine in locally advanced bladder cancer. Int J Radiat Oncol Biol Phys. 2005;61(2):420\u20135. doi: 10.1016\/j.ijrobp.2004.05.074 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9136_CR16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1006\/gyno.2001.6197","volume":"81","author":"P Pattaranutaporn","year":"2001","unstructured":"Pattaranutaporn P, et al. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage III B cervical carcinoma. Gynecol Oncol. 2001;81:404\u20137. doi: 10.1006\/gyno.2001.6197 .","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9136_CR17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/srao.2003.50006","volume":"13","author":"CN Andreassen","year":"2003","unstructured":"Andreassen CN, Grau C, Lindegaard JC. Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy. Semin Radiat Oncol. 2003;13(1):62\u201372. doi: 10.1053\/srao.2003.50006 .","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"9136_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/srao.2002.31382","volume":"12","author":"DR Cassatt","year":"2002","unstructured":"Cassatt DR, Fazenbaker CA, Bachy CM, Hanson MS. Preclinical modeling of improved amifostine (ethyol) use in radiation therapy. Semin Radiat Oncol. 2002;12(1):97\u2013102. doi: 10.1053\/srao.2002.31382 .","journal-title":"Semin Radiat Oncol"},{"key":"9136_CR19","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/1097-0142(19941015)74:8<2379::AID-CNCR2820740825>3.0.CO;2-J","volume":"74","author":"JP Delaney","year":"1994","unstructured":"Delaney JP, Bonsack ME, Felemovicius I. Radioprotection of the rat small intestine with topical WR-2721. Cancer. 1994;74:2379\u201384. doi:10.1002\/1097-0142(19941015)74:8<2379::AID-CNCR2820740825>3.0.CO;2-J.","journal-title":"Cancer"},{"key":"9136_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0360-3016(86)90096-9","volume":"12","author":"H Ito","year":"1986","unstructured":"Ito H, Meistrich ML, Barkley HT, Thames HD, Milas L. Protection of acute and late radiation damage of the gastrointestinal tract by WR-2721. Int J Radiat Oncol Biol Phys. 1986;12:211\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"9136_CR21","first-page":"64","volume":"23","author":"S Wadler","year":"1996","unstructured":"Wadler S, et al. The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix. Semin Oncol. 1996;23(8):64\u20138.","journal-title":"Semin Oncol"},{"key":"9136_CR22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0360-3016(93)90957-W","volume":"26","author":"N Mitsuhashi","year":"1993","unstructured":"Mitsuhashi N, Takahashi I, Takahashi M. Clinical study of radioprotective effects of amifostine (YM-08310, WR-2721) on long-term outcome for patients with cervical cancer. Int J Radiat Oncol Biol Phys. 1993;26:407\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9136_CR23","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1002\/1097-0142(19920601)69:11<2820::AID-CNCR2820691130>3.0.CO;2-T","volume":"69","author":"T Liu","year":"1992","unstructured":"Liu T, Liu Y, He S, Zhang Z, Kligerman MM. Use of radiation with or without WR-2721 in advanced rectal cancer. Cancer. 1992;69:2820\u20135. doi:10.1002\/1097-0142(19920601)69:11<2820::AID-CNCR2820691130>3.0.CO;2-T.","journal-title":"Cancer"},{"key":"9136_CR24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0360-3016(92)90527-O","volume":"22","author":"MM Kligerman","year":"1992","unstructured":"Kligerman MM, et al. Interim analysis of a randomized trial of radiation therapy of rectal cancer with\/without WR-2721. Int J Radiat Oncol Biol Phys. 1992;22:799\u2013802.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9136_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00066-003-0970-y","volume":"179","author":"J Kouvaris","year":"2003","unstructured":"Kouvaris J, et al. Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy. Strahlenther Onkol. 2003;179:167\u201374. doi: 10.1007\/s00066-003-0970-y .","journal-title":"Strahlenther Onkol"},{"key":"9136_CR26","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0360-3016(03)00187-1","volume":"56","author":"H Athanassiou","year":"2003","unstructured":"Athanassiou H, et al. Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. Int J Radiat Oncol Biol Phys. 2003;56:1154\u201360. doi: 10.1016\/S0360-3016(03)00187-1 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"9136_CR27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ijrobp.2005.06.023","volume":"64","author":"AD Sasse","year":"2006","unstructured":"Sasse AD, Clark LG, Sasse EC, Clark OA. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int J Radiat Oncol Biol Phys. 2006;64(3):784\u201391. doi: 10.1016\/j.ijrobp.2005.06.023 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9136_CR28","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0360-3016(01)01737-0","volume":"51","author":"AA Yavuz","year":"2001","unstructured":"Yavuz AA, Ayd\u0131n F, Yavuz MN, Ilis E, Ozdemir F. Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice weekly gemcitabine advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2001;51:974\u201381. doi: 10.1016\/S0360-3016(01)01737-0 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"9136_CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/IJGC:29:1:19","volume":"29","author":"TP Phan","year":"2001","unstructured":"Phan TP, et al. WR-2721 reduces intestinal toxicity from concurrent Gemcitabine and radiation treatment. Int J Pancreatol. 2001;29(1):19\u201323. doi: 10.1385\/IJGC:29:1:19 .","journal-title":"Int J Pancreatol"},{"key":"9136_CR30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0959-8049(03)00002-9","volume":"39","author":"B Pauwels","year":"2003","unstructured":"Pauwels B, et al. The radiosensitizing effect of gemcitabine and the influence of the rescue agent amifostine in vitro. Eur J Cancer. 2003;39:838\u201346. doi: 10.1016\/S0959-8049(03)00002-9 .","journal-title":"Eur J Cancer"},{"key":"9136_CR31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1097-0142(19800201)45:3<444::AID-CNCR2820450307>3.0.CO;2-#","volume":"45","author":"W Black","year":"1980","unstructured":"Black W, Gomez L, Yuhas JM, Kligerman MM. Quantitation of the late effects of X-radiation on the large intestine. Cancer. 1980;45:444\u201351. doi:10.1002\/1097-0142(19800201)45:3<444::AID-CNCR2820450307>3.0.CO;2-#.","journal-title":"Cancer"},{"key":"9136_CR32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/33.8.2410480","volume":"33","author":"A Lopez Leon de","year":"1985","unstructured":"de Lopez Leon A, Rojkind M. A simple micromethod for collagen and total protein determination informalin-fixed paraffin-embedded sections. J Histochem Cytochem. 1985;33:737\u201343.","journal-title":"J Histochem Cytochem"},{"key":"9136_CR33","unstructured":"\u015eahinler \u0130, et al. The effectiveness of amifostine in preventing vaginal fibrosis due to irradiation in rats. 21st Annual ESTRO Meeting, Praha, Czech Republic, 17\u201321 September, 2002. Radiotherapy and Oncology 2002;64 (Suppl 1)."},{"key":"9136_CR34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/02841868309134045","volume":"22","author":"M Hauer-Jensen","year":"1983","unstructured":"Hauer-Jensen M, Sauer T, Devik F, Nygaard K. Late changes following single dose roentgen irradiation of rat small intestine. Acta Radiol Oncol. 1983;22:299\u2013303. doi: 10.3109\/02841868309134045 .","journal-title":"Acta Radiol Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-008-9136-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-008-9136-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-008-9136-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:22:36Z","timestamp":1559442156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-008-9136-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,30]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9136"],"URL":"https:\/\/doi.org\/10.1007\/s12032-008-9136-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,30]]}}}